Experienced in Epilepsy

Mirian C. Janssen

Nijmegen, GE, NL 
Experienced in Epilepsy
Nijmegen, GE, NL 
OverviewLocationsClinical Research

Overview

Mirian Janssen practices in Nijmegen, Netherlands. Ms. Janssen is rated as an Experienced expert by MediFind in the treatment of Epilepsy. Her top areas of expertise are Classic Galactosemia, Ballinger-Wallace Syndrome, MELAS Syndrome, Galactosemia, and Kidney Transplant.

Her clinical research consists of co-authoring 155 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 8 articles in the study of Epilepsy.

Gender
Female

Locations

Nijmegen, GE, Netherlands
Other Locations
Venlo, LI, Netherlands
Maastricht, LI, Netherlands
Spaarne Gasthuis
Haarlem, NH, Netherlands
Arnhem, GE, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase IIb Open-label, Multi-centre, Extension Study to Explore the Long-term Safety and Efficacy of KH176 in Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation Who Have Completed the KHENERGYZE Study KH176-202.
A Phase IIb Open-label, Multi-centre, Extension Study to Explore the Long-term Safety and Efficacy of KH176 in Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation Who Have Completed the KHENERGYZE Study KH176-202.
Enrollment Status: Completed
Publish Date: March 06, 2024
Intervention Type: Drug
Study Drug: KH176
Study Phase: Phase 2
A Phase IIb Double-blind, Randomised, Placebo-controlled, Multi-centre, Confirmative Three-way Cross-over Study on Cognitive Function With Two Doses of KH176 in Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation.
A Phase IIb Double-blind, Randomised, Placebo-controlled, Multi-centre, Confirmative Three-way Cross-over Study on Cognitive Function With Two Doses of KH176 in Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation.
Enrollment Status: Completed
Publish Date: August 31, 2022
Intervention Type: Drug
Study Drug: KH176
Study Phase: Phase 2
An Exploratory, Double-blind, Randomized, Placebo-controlled, Single-center, Two-way Cross-over Study With KH176 in Patients With the Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation and Clinical Signs of Mitochondrial Disease
An Exploratory, Double-blind, Randomized, Placebo-controlled, Single-center, Two-way Cross-over Study With KH176 in Patients With the Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation and Clinical Signs of Mitochondrial Disease
Enrollment Status: Completed
Publish Date: February 23, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

155 Total Publications

Inherited metabolic disorders in adults:growing patient numbers, advanced diagnostic tools and new treatment modalities
Inherited metabolic disorders in adults:growing patient numbers, advanced diagnostic tools and new treatment modalities
Journal: Nederlands tijdschrift voor geneeskunde
Published: July 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Janssen's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 8 Advanced Conditions
    View All 45 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile